Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
Life (Basel, Switzerland)
|
August 28, 2025
Impact of Chromosomal Structural Rearrangements on IVF Laboratory Outcomes in PGT-SR Cycles: A Propensity Score Matching-Based Study
Daria Marzanati, Sara D'Alessandro, Davide Gentilini, et al.
Molecular and Cellular Endocrinology
|
December 7, 2021
Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line
Silvia Limoncella, Clara Lazzaretti, Elia Paradiso, et al.
Journal of Medical Virology
|
February 7, 2026
Torque Teno Virus Levels During Viral Respiratory Infections: The Interplay With Immune Dysregulation and Coagulopathy Biomarkers
Roberto Ferrarese, Pietro Giorgio Spezia, Sara Boutahar, et al.
International Journal of Biological Macromolecules
|
June 15, 2025
Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin
Clara Lazzaretti, Elia Paradiso, Samantha Sperduti, et al.
Experimental Neurology
|
March 30, 2017
A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis
Stefania Marcuzzo, Silvia Bonanno, Matteo Figini, et al.
Human Reproduction (Oxford, England)
|
November 11, 2022
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro
Samantha Sperduti, Elia Paradiso, Claudia Anzivino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study
Roberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.
The Oncologist
|
April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
Life (Basel, Switzerland)
|
August 28, 2025
Impact of Chromosomal Structural Rearrangements on IVF Laboratory Outcomes in PGT-SR Cycles: A Propensity Score Matching-Based Study
Daria Marzanati, Sara D'Alessandro, Davide Gentilini, et al.
Molecular and Cellular Endocrinology
|
December 7, 2021
Phosphodiesterase (PDE) 5 inhibitors sildenafil, tadalafil and vardenafil impact cAMP-specific PDE8 isoforms-linked second messengers and steroid production in a mouse Leydig tumor cell line
Silvia Limoncella, Clara Lazzaretti, Elia Paradiso, et al.
Journal of Medical Virology
|
February 7, 2026
Torque Teno Virus Levels During Viral Respiratory Infections: The Interplay With Immune Dysregulation and Coagulopathy Biomarkers
Roberto Ferrarese, Pietro Giorgio Spezia, Sara Boutahar, et al.
International Journal of Biological Macromolecules
|
June 15, 2025
Trafficking of luteinizing hormone receptor directs the differential signal activation between luteinizing hormone and chorionic gonadotropin
Clara Lazzaretti, Elia Paradiso, Samantha Sperduti, et al.
Experimental Neurology
|
March 30, 2017
A longitudinal DTI and histological study of the spinal cord reveals early pathological alterations in G93A-SOD1 mouse model of amyotrophic lateral sclerosis
Stefania Marcuzzo, Silvia Bonanno, Matteo Figini, et al.
Human Reproduction (Oxford, England)
|
November 11, 2022
LH increases the response to FSH in granulosa-lutein cells from sub/poor-responder patients in vitro
Samantha Sperduti, Elia Paradiso, Claudia Anzivino, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 1, 2026
Denosumab is associated with longer real-world progression-free survival in BRCA1/2-mutated HR+ /HER2 - breast cancer patients with bone metastases receiving CDK4/6 inhibitors: A multicenter Italian study
Roberta Scafetta, Raffaella Troiano, Carla Gullotta, et al.
The Oncologist
|
April 17, 2026
Comparative real-world Progression Free Survival of CDK4/6 Inhibitors in HR+/HER2- Breast Cancer Patients with Bone Metastases
Roberta Scafetta, Marco Donato, Carla Gullotta, et al.
Page
of 2